drugset / Trial / NCT00452179

Safety and Efficacy Study of APD125 in Patient With Insomnia

NCT00452179 ↗

Phase 2 Completed 173 enrolled Arena Pharmaceuticals
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine the effects of APD125 in patients with sleep maintenance insomnia.

Timeline

Start
2007-02
Primary completion
—
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nelotanserin Small molecule — —

Indications